Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

41.03
Delayed Data
As of 4:02pm ET
 -0.0242 / -0.06%
Today’s Change
37.20
Today|||52-Week Range
45.58
+6.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues8.8B9.3B9.9B9.4B
 
 
 
 
 
Cost of Goods Sold2.2B2.4B3.0B2.0B
 
 
 
 
 
Depreciation And Amortization790.4M569.0M250.6M878.3M
 
 
 
 
 
 
Operating ExpensesGross Income5.9B6.3B6.7B6.5B
 
 
 
 
 
General Expenses4.0B4.0B4.0B4.3B
 
 
 
 
 
Other Operating Expenses0.000.000.00-35.8M
 
 
Research And Development1.1B1.1B1.1B1.3B
 
 
 
 
 
Total Operating Expenses6.9B7.0B7.2B7.1B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.9B2.3B2.7B2.2B
 
 
 
 
 
Extraordinary Credit0.000.0011.8M100.1M
 
 
 
Extraordinary Charge-956.1M-2.9B-1.3B-1.7B
 
 
 
 
 
Interest Expense On Debt250.7M256.9M230.9M238.4M
 
 
 
 
 
Equity In Earnings0.00-2.8M7.9M1.2M
 
 
 
 
Other Expenses158.6M410.1M511.7M144.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income793.2M-448.4M1.7B521.3M
 
 
 
 
 
Income Taxes-294.6M-246.9M-510.4M-130.9M
 
 
 
 
 
Minority Interest-99.2M-80.9M-101.0M-74.1M
 
 
 
 
 
Net Income399.4M-617.3M1.1B317.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.4B2.4B2.4B2.4B
 
 
 
 
 
Shares To Calculate EPS Diluted2.4B2.4B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.16-$0.26$0.44$0.13
 
 
 
 
 
EPS Diluted$0.16-$0.26$0.43$0.13